U.S. flag

An official website of the United States government

Display Settings:

Format
Sort by

Send to:

Choose Destination

Links from BioSystems

Items: 5

1.
Signaling crosstalk between RANKL and interferons in osteoclast differentiation
Hiroshi Takayanagi, Sunhwa Kim, Tadatsugu Taniguchi
Arthritis Res. 2002; 4(Suppl 3): S227–S232. Published online 2002 May 9. doi: 10.1186/ar581
PMCID:
PMC3240156
ArticlePDF–115K
2.
Novel functions for NFκB: inhibition of bone formation
Susan A. Krum, Jia Chang, Gustavo Miranda-Carboni, Cun-Yu Wang
Nat Rev Rheumatol. Author manuscript; available in PMC 2011 Apr 18.
Published in final edited form as: Nat Rev Rheumatol. 2010 Oct; 6(10): 607–611. Published online 2010 Aug 10. doi: 10.1038/nrrheum.2010.133
PMCID:
PMC3078572
ArticlePDF–250K
3.
Osteoimmunology: Interactions of the Bone and Immune System
Joseph Lorenzo, Mark Horowitz, Yongwon Choi
Endocr Rev. 2008 Jun; 29(4): 403–440. Published online 2008 May 1. doi: 10.1210/er.2007-0038
PMCID:
PMC2528852
Article
4.
Deubiquitinating enzyme CYLD negatively regulates RANK signaling and osteoclastogenesis in mice
Wei Jin, Mikyoung Chang, Emmanuel M. Paul, Geetha Babu, Andrew J. Lee, William Reiley, Ato Wright, Minying Zhang, Jun You, Shao-Cong Sun
J Clin Invest. 2008 May 1; 118(5): 1858–1866. Published online 2008 Apr 1. doi: 10.1172/JCI34257
PMCID:
PMC2276399
ArticlePDF–1.6M
5.
FHL2 inhibits the activated osteoclast in a TRAF6-dependent manner
Shuting Bai, Hideki Kitaura, Haibo Zhao, Ju Chen, Judith M. Müller, Roland Schüle, Bryant Darnay, Deborah V. Novack, F. Patrick Ross, Steven L. Teitelbaum
J Clin Invest. 2005 Oct 1; 115(10): 2742–2751. Published online 2005 Sep 22. doi: 10.1172/JCI24921
PMCID:
PMC1224296
ArticlePDF–1.2M

Display Settings:

Format
Sort by

Send to:

Choose Destination

Supplemental Content

Filter your results:

Find related data

Recent activity

You are here: NCBI > Literature > PubMed Central (PMC)
Support Center